The Experimental and Clinical Pharmacology graduate program at the University of Minnesota College of Pharmacy is an innovative, interdisciplinary program that trains students to conduct research encompassing methodology from basic and clinical pharmacology perspectives. In our program, students study:
Graduates are prepared for distinguished careers in clinical research
- Experimental Pharmacotherapy
- Infectious Disease
- Pharmacogenomics Research
- NEW - Applied Pharmacogenomics (MS only)
When faced with a cancer diagnosis, a patient’s and his or her care team’s primary concern is to confront and eliminate the imminent threat the cancer poses to the patient’s life and health. However, for many cancer survivors, cancer remission is not necessarily the end of health challenges related to the disease. Cancer treatment frequently causes long-term, sometimes silent, damage to critical organs and systems that can result in chronic diseases and reduce quality of life or life expectancy for cancer survivors.
Associate Professor Beshay Zordoky would like to help cancer survivors move on from illness, rather than from one illness to the next.
Read more about Dr. Zordoky's career and his work on the long-term effects of chemotherapy in the Spring 2019 issue of the ECP Gazette.
Advancing the science of human pharmacology and therapeutics through translational research
This cross-disciplinary paradigm translates basic scientific discoveries into safe and effective therapeutic uses by providers and patients, through laboratory experiments and clinical studies. Clinical data can also prompt new questions and investigations, leading back to the bench and beginning a new cycle of translational research. Research conducted by department faculty can focus on a range of topics, diseases/conditions, and investigational methods. Some current and recent projects are highlighted here:
- Alzheimer's Disease
- Community Health
- Drug Dependence
- Pharmacometrics/ Pharmacokinetic modeling
- Seizure Disorders
- Infectious Disease